ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Solomon Gard’s Questions/Answers

January 2, 1981

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001

DRCCA Board Okays Cooperative Group Contract Extension, Nutrition Research Training Grants

February 6, 1981

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009